Author of

• 20015

  +

  Is there a role for second-line immunotherapy in patients with PD-L1 negative NSCLC? (ID 22)

  • Event: ELCC 2017
  • Type: Controversy session
  • Track:
  • Presentations: 1
  • Moderators:M. Reck, L. Paz-Ares
  • Coordinates: 5/07/2017, 09:15 - 10:15, Room A

  • 20017

    +

    Yes (ID 90)

    09:15 - 10:15  |  Author(s): R. Herbst
    • Abstract
    • Presentation
    • Slides

    Abstract not provided

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.